Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: Evidence from a systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference59 articles.
1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010
2. Cancer Statistics, 2009;Jemal;CA Cancer J Clin,2009
3. International trends and patterns of primary liver cancer;McGlynn;Int J Cancer,2001
4. Trends in mortality from primary liver cancer in Europe;La Vecchia;Eur J Cancer,2000
5. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies;Tandon;Liver Int,2009
Cited by 101 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bulk and single‐cell transcriptome reveal the immuno‐prognostic subtypes and tumour microenvironment heterogeneity in HCC;Liver International;2024-01-31
2. Identification and development of TP53 mutation-associated Long non-coding RNAs signature for optimized prognosis assessment and treatment selection in hepatocellular carcinoma;International Journal of Immunopathology and Pharmacology;2023-11-09
3. Role of immune related genes in predicting prognosis and immune response in patients with hepatocellular carcinoma;Journal of Biochemical and Molecular Toxicology;2023-09-04
4. Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia;Computers in Biology and Medicine;2023-09
5. Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma;Cancers;2023-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3